Effects of secretory products of breast cancer cells on osteoblast-like cells

Breast Cancer Research and Treatment

Volumn 38, Issue 2, 1996, Pages 209-216

  Lacroix, Marc ^a   Siwek, Brigitte ^a   Body, Jean Jacques ^a,b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b JULES BORDET INSTITUTE   (Belgium)

Author keywords

Bone metastases; Breast cancer; Osteoblasts; Osteolysis; Parathyroid; Prostaglandins

Indexed keywords

CYCLIC AMP; ESTRADIOL; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; POLYCLONAL ANTIBODY; PROSTAGLANDIN E2; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL; CELL GROWTH; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOLYSIS; PATHOGENESIS; PRIORITY JOURNAL; TARGET CELL;

ADENOCARCINOMA; BREAST NEOPLASMS; CELL DIVISION; CULTURE MEDIA, CONDITIONED; CYCLIC AMP; DINOPROSTONE; FEMALE; FORSKOLIN; HUMANS; OSTEOBLASTS; OSTEOLYSIS; PARATHYROID HORMONE; PARATHYROID HORMONE-RELATED PROTEIN; PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0030012102     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806675     Document Type: Article

References (29)

1. Coleman RE, Rubens RD: The clinical course of bone metastases from breast cancer. Br J Cancer 55: 61-66, 1987
2. Body JJ: Bone metastases and tumor-induced hypercalcemia. Curr Opin Oncol 4: 624-631, 1992
3. McSheehy PMJ, Chambers TJ: Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. Endocrinology 119: 1654-1659, 1986
4. McSheehy PMJ, Chambers TJ: 1,25-dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption. J Clin Invest 80: 425-429, 1987
5. Thomson BM, Saklatvala J, Chambers TJ: Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts. J Exp Med 164: 104-112, 1986
6. Rodan SB, Imai Y, Thiede MA, Wesolowski G, Thompson D, Bar-Shavit Z, Shull S, Mann, Rodan GD: Characterization of a human osteosarcoma cell line (SaOS-2) with osteoblastic properties. Cancer Res 47: 4961-4966, 1987
7. 2 stimulation of cAMP production. J Immunol 145: 1231-1237, 1990
8. 2, parathyroid hormone, and epidermal growth factor on mitogenesis, signaling, and primary response genes in UMR 106-01 osteoblast-like cells. Endocrinology 131: 2113-2119, 1992
9. Polanowski FP, Gaffney EV, Burke RE: HBL-100, a new cell line established from human breast milk. In Vitro 12: 328-338, 1976
10. Lippman ME, Bolan G, Huff K: The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term culture. Cancer Res 36: 4610-4618, 1976
11. Danielpour D, Dart LL, Flanders KC, Roberts AB, Sporn MB: Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-β-1 and TGF-β-2) secreted by cells in culture. J Cell Physiol 138: 79-86, 1989
12. Sorger T, Germinario RJ: A direct solubilization procedure for the determination of DNA and protein in cultured fibroblast monolayers. Anal Biochem 131: 254-256, 1983
13. Heath H III, Purnell DC: Urinary cyclic 3′,5′-adenosine monophosphate responses to exogenous and endogenous parathyroid hormone in familial benign hypercalcemia and primary hyperparathyroidism. J Lab Clin Med 96: 974-984, 1980
14. Body JJ, Borkowski A, Cleeren A, Bijvoet OLM: Treatment of malignancy-associated hypercalcemia with intravenous aminohydroxypropylidene diphosphonate. J Clin Oncol 4: 1177-1183, 1986
15. Stewart AF, Vignery A, Silverglate A, Ravin ND, Li Volsi V, Broadus AE, Baron R: Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. J Clin Endocrinol Metab 55: 219-227, 1982
16. Hujanen ES, Terranova VP: Migration of tumor cells to organ-derived chemoattractants. Cancer Res 45: 3517-3521, 1985
17. Dickson RB, Lippman ME: Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocrine Rev 8: 29-43, 1987
18. Hurley MM, Fall P, Harrison JR, Petersen DN, Kream BE, Raisz LG: Effects of transforming growth factor alpha and interleukin-1 on DNA synthesis, collagen synthesis, procollagen mRNA levels and prostaglandin E, production in cultured fetal rat calvaria. J Bone Miner Res 4: 731-736, 1989
19. Centrella M, McCarthy TL, Canalis E: Platelet-derived growth factor enhances deoxyribonucleic acid and collagen synthesis in osteoblast-enriched cultures from fetal rat parietal bone. Endocrinology 125: 13-19, 1989
20. Hock JM, Centrella M, Canalis E: Insulin-like growth factor has independent effects on bone matrix formation and cell replication. Endocrinology 122: 254-260, 1988
21. Gutierrez GE, Mundy GR, Derynck R, Hewlett ER, Katz MS: Inhibition of parathyroid hormone-responsive adenylate cyclase in clonal osteoblast-like cells by transforming growth factor alpha and epidermal growth factor. J Biol Chem 262: 15845-15850, 1987
22. 2-stimulated adenosine 3′,5′-monophosphate production by human osteoblast-like SaOS-2 cells. Endocrinology 133: 1585-1592, 1993
23. Guenther HL, Cecchini MG, Elford PR, Fleisch H: Effects of transforming growth factor type beta upon bone cell populations grown either in monolayer or semisolid medium. J Bone Miner Res 3: 269-278, 1988
24. Noda M, Rodan GA: Type-beta transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells. Biochem Biophys Res Commun 140: 57-65, 1986
25. Datta HK, Zaidi M, Champaneri JB, MacIntyre I: Transforming growth factor-beta-induced mitogenesis of human bone cancer cells. Biochem Biophys Res Commun 161: 672-676, 1989
26. Centrella M, McCarthy TL, Canalis E: Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem 262: 2869-2874, 1987
27. Gutierrez GE, Mundy GR, Manning DR, Hewlett EL, Katz MS: Transforming growth factor beta enhances parathyroid hormone stimulation of adenylate cyclase in clonal osteoblast-like cells. J Cell Physiol 144: 438-447, 1990
28. Schneider HG, Michelangeli VP, Frampton RJ, Grogan JL, Ikeda K, Martin TJ, Findlay DM: Transforming growth factor-beta modulates receptor binding of calciotropic hormones and G protein-mediated adenylate cyclase responses in osteoblast-like cells. Endocrinology 131: 1383-1389, 1992
29. Seitz PK, Zhu BT, Cooper CW: Effect of transforming growth factor beta on parathyroid hormone receptor binding and cAMP formation in rat osteosarcoma cells. J Bone Miner Res 7: 541-546, 1992